Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.16%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.82%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter1.35%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-4.08%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year5.63%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range56.43 - 77.12 Perf YTD5.69%
Dividend0.99 P/FCF- EPS past 5Y- ROI- 52W High-6.68% Beta-
Dividend %1.38% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low27.55% ATR1.10
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)59.90 Volatility1.22% 1.41%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.21 Prev Close71.56
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume17.88M Price71.97
Recom- SMA200.80% SMA503.26% SMA200-0.54% Volume2,069,380 Change0.57%
Nov-24-15 09:52AM  Basics of the Allergan-Pfizer Merger
09:50AM  The Allergan-Pfizer Merger: Another Big Inversion Transaction
Nov-23-15 05:15PM  Takedas Ninlaro and Its Approval for Multiple Myeloma Treatment
12:00PM  Politicians react to Pfizer's inversion
10:07AM  How is the Pharmaceutical Subgroup of XLV Performing?
09:24AM  UnitedHealth Group Updates Its 2015 Guidance
Nov-22-15 11:02AM  Sanofi Sets Its Sights on 2020 -- Here's What Investors Need to Know at Motley Fool
Nov-20-15 12:58PM  SPY Heavy as UnitedHealth Group Forewarned Profit
10:07AM  How Did the Biotechnology Subgroup of XLV Perform?
08:34AM  Health care is the best pick for 2016, despite Thursday's drop: Strategist
08:13AM  Health coverage must focus on cost control: Expert
08:11AM  Obamacare transitioning to Medicaid mode: Scott Gottlieb
08:09AM  How PerkinElmer Topped the XLVs Mid-Cap Stocks
08:08AM  Why health exchanges must be mandatory...
05:00AM  Buy Health Care After Big Slide? Nike Ups Buyback, Splits Stock at TheStreet
Nov-19-15 05:00PM  Safe havens in healthcare? 6 trades to make
02:07PM  Vertex Rises on Two EU Approvals for Drug, Leads XLVs Large-Caps
02:07PM  XLV Gained Momentum on Strong Market
01:34PM  Favorite market spots for your money
01:23PM  JPM and BAC Rose Due to the Likelihood of a Rate Hike
01:14PM  FDA Approval of Johnson & Johnsons Darzalex for Multiple Myeloma
09:29AM  Pfizer in Talks to Buy Allergan: Prescribed ETFs
09:13AM  Holiday shopping to be the strongest in nearly a decade: Strategist
Nov-18-15 02:40PM  Should drug ads be banned?
Nov-17-15 08:22AM  Perrigo Considered Mylans Offer to Be Dilutive to EPS
Nov-13-15 12:05PM  Could the Rite AidWalgreens Merger Get Competitive?
Nov-12-15 12:04PM  Notable option activity in equities
09:04AM  Parsing the Rite Aid-Walgreens MAE Clause: Part 1
09:01AM  Rite Aid-Walgreens Merger: What Does Rite Aid Bring to the Table?
Nov-11-15 08:17AM  Combinations & Permutations - Algebra 101 - Try the Linguine w/Sweet Vinegar Pepper Sauce
Nov-10-15 09:48AM  Quant Trade Ideas
08:05AM  Cheap oil may be good for gas guzzlers but not for the S&P 500
Nov-09-15 07:06PM  Can the Walgreens-Rite Aid Merger Get Antitrust Approval?
05:30PM  The most expensive sectors
11:47AM  Celgene Sees Year-over-Year Revenue Growth of 17.8%
10:07AM  Rationale for the Rite AidWalgreens Merger
07:47AM  The Top Healthcare ETF on the Market at Motley Fool
Nov-06-15 02:06PM  Investing after a blowout jobs report
12:08PM  Henry Schein Trades above Its 100-Day Moving Average
10:18AM  Anthem deal expands choice: Cigna CEO
10:15AM  Tenet Healthcare Posts Good 3Q15 Earnings, Drives XLVs Mid-Caps
10:15AM  The Large-Cap Stocks of XLV Remained Flat on November 3
10:12AM  Cigna CEO on earnings beat and Obamacare
09:50AM  The Proper Context of Hedge Fund Money ETFguide
Nov-05-15 04:56PM  Best & worst sectors for the next Best Six Months
03:42PM  Chinese economy stabilizing: Ulrich
03:39PM  30 minutes to close: Unusual volume
07:07AM  Bayer CEO: Europe's 'precautionary principle' at play
Nov-04-15 06:22PM  Mallinckrodt Helps Pharmaceutical Subgroup of XLV to Outperform
06:20PM  XLV Traded Sideways on Profit Booking on November 2
05:13PM  Drug trade following pricing probe
11:08AM  Amgens Late-Stage Pipeline Continues to Advance in 3Q15
10:51AM  3 High-Momentum Health Care Stocks That Will Keep Their Mojo in 2016 at TheStreet
07:26AM  Jobs Reports and the Parade of Clowns - Try the Timbale di Riso
Nov-03-15 12:09PM  Amgens Oncology Drugs Register Solid Growth In 3Q15
11:18AM  Valeant: How Much Will the Philidor Loss Hurt? at
10:21AM  Basics of the Rite AidWalgreens Merger
10:16AM  The Rite AidWalgreens Merger: Walgreens Moves to Rival CVS
08:38AM  The Early Bird Catches the Worm Try the Halibut
07:37AM  Get ready for a bigger Santa Claus rally: Strategist
Nov-02-15 02:52PM  5 Best Performing Stocks of October
02:11PM  Making sense of Valeant's free fall
01:46PM  Obamacare 3.0 kickoff
10:29AM  Cashin: Great deal of risk, Fed won't raise Dec.
10:06AM  Biogens Valuation Multiple Rises Marginally Post-3Q15 Earnings
09:59AM  Valeant Pharmaceuticals: Two Analysts Down, 16 to Goand This Time It's Goldman at
Oct-30-15 02:57PM  Pfizer and Allergan: Possibly the Largest Merger
12:10PM  Celgene 3Q15: Focus on Inflammation and Immunology Drugs
11:33AM  Science behind Theranos in question
10:34AM  NYT's Stewart: Theranos 'sensational idea,' but no peer r...
09:06AM  How Endo Helped XLVs Pharmaceutical Subgroup Outperform SPY
08:06AM  How Allergan Helped XLVs Top Ten Large-Cap Stocks on October 26, 2015
07:54AM  Why we schedule simultaneous surgeries: Mayo Clinic
07:48AM  Theranos technology needs to be verified: Dr. Toby Cosgro...
07:37AM  Why we've stopped hiring smokers: Dr. Toby Cosgrove
07:36AM  We've stopped hiring smokers: Dr. Toby Cosgrove
07:32AM  Politics of managing health care costs
07:09AM  US paying 'premium' for drugmakers: Toby Cosgrove
07:08AM  Financial pressures driving hospital efficiencies: Toby C...
07:04AM  Hospitals of the future: Reining in costs
Oct-27-15 11:25AM  How Celgene Reacted to Positive Clinical Trials on October 26, 2015
11:25AM  Assessing Laboratory Corporations Strong Performance in 3Q15
09:57AM  Valeant: Wait, One Analyst Sees Less Risk, Limited Downside? at
09:08AM  Biogen: Interferon Therapy and Tysabri Continue Modest Growth
09:08AM  Huge Dispersion In Hedge Fund Returns In October: Blame Health Care at
07:19AM  Biotech ETFs: Buy, Buy, Buy?
Oct-26-15 04:46PM  [$$] Hospital Stocks Can Rally Amid Health-Care Slump at
03:40PM  Valeant: 'Regaining Investor Credibility is the Single Most Important Thing' at
02:07PM  What Factors Affected Gilead Sciences HIV Segment in 3Q15?
01:17PM  Why Health Care Could Be the Best Performing SectorNext Year at
10:14AM  Roughed Up Health-Care ETFs Could Rally Into Year-End at
Oct-23-15 12:06PM  XLVs Pharmaceutical Subgroup in Mid-October: Endo International Dragging
11:16AM  Athenahealth up 22% after beat
Oct-22-15 09:49PM  Tech, Banks and Health Care are half of the US stock market
03:30PM  The worst is yet to come in health care: Pro
03:07PM  XLVs Bottom Ten in Mid-October: Tenet Healthcare on Top
03:07PM  Biogen Has Strong Research and Development Pipeline in 3Q15
02:09PM  Health groups appeal to Turing on drug price
Oct-21-15 12:45PM  Healthcare and Technology Stocks Weigh Down SPY
12:37PM  XLVs Top Ten Large-Caps in Mid-October: Allergan Sheds the Most
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.